MedTrace Logo

Salivary Expression of SOX7 in Oral Squamous Cell Carcinoma: Diagnostic Accuracy Study

NCT06031337 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 46

Last updated 2024-09-27

No results posted yet for this study

Summary

The study will include patients with oral cancer and healthy controls of both sexes. Subjects having any systemic diseases or other types of cancer will be excluded. All subjects will be selected from Oral Medicine Department, Faculty of Dentistry, Al Ahram Canadian University and Fayoum University. Informed consent will be obtained from all subjects enrolled in this study after explanation of the whole procedure.

Conditions

  • Oral Cancer
  • Oral Squamous Cell Carcinoma

Interventions

DIAGNOSTIC_TEST

ELISA

quantitative determination of salivary SOX7 using an Enzyme Linked Immunosorbent assay (ELISA) kit based on the sandwich principle according to the manufacturer's protocol.

Sponsors & Collaborators

  • Fayoum University

    lead OTHER

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-09-03
Primary Completion
2023-11-22
Completion
2023-12-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06031337 on ClinicalTrials.gov